Clinical Trial Update: Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of maintenance treatment with recombinant human thrombopoietin (rhTPO) in patients with immune thrombo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Peking Union Medical College | Conditions: Thrombocytopenia, Immune Thrombocytopenia | Phase 3 | Status: UNKNOWN